États-Unis · Bourse & Finance · Yahoo Finance

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

Publié par Yahoo Finance · États-Unis il y a 10 h

REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, is added to the alliance, along with a long-acting IL-4xIL-13 bispecific and…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

À lire aussi

Regeneron drug said to cut muscle loss when combined with Novo's semaglutide

Bitcoin think tank questions MSCI’s ‘invisible committee’ over Strategy, Metaplanet rule

South Korean President Lee pushes back on Alaska LNG project after Trump touts Seoul's participation

Brent Tumbles to $96 as Gulf Oil Flows Bounce Back

Dogecoin gets DeFi testnet as DogeOS bets miners will eventually secure its apps

I was lonely and working 15-hour days in the US. Moving to the Philippines gave me a community.

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

Partager

À lire aussi

Regeneron drug said to cut muscle loss when combined with Novo's semaglutide

Bitcoin think tank questions MSCI’s ‘invisible committee’ over Strategy, Metaplanet rule

South Korean President Lee pushes back on Alaska LNG project after Trump touts Seoul's participation

Brent Tumbles to $96 as Gulf Oil Flows Bounce Back

Dogecoin gets DeFi testnet as DogeOS bets miners will eventually secure its apps

I was lonely and working 15-hour days in the US. Moving to the Philippines gave me a community.